XOStem
M. Reza MohammadiM, PhD is member of the XOStem Science Advisory Board and received his PhD degree in Materials Science and Engineering with a concentration in exosome therapy. His research demonstrated the cellular and molecular pathways underlying the therapeutic efficacy of exosomes in treating a multiple sclerosis model in rodents. He developed a hybrid biomaterial that regulates the local immune system nearby to cellular implants, protecting the transplanted cells from host immune attack. Prior to his PhD work, Dr. Moammadi was a research scientist at Stanford University where he focused on interactions between nanomaterials and the immune system. .
This person is not in the org chart
This person is not in any teams
This person is not in any offices
XOStem
XOStem is the stem cell expert that creates the next generation treatment for Type 1 Diabetes and produces Engineered Exosomes.